Avalo Therapeutics, Inc. (AVTX) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Earnings Reports
-
AVTX Q3 2025: Portfolio Yield Climbs to 18.6% as Monroe Merger Sets Up Scale Leap
October 29, 2025
-
Horizon Technology Finance (AVTX) Q3 2024: Portfolio Grows 6% as Backlog Hits $190M, Pipeline Surges
October 30, 2024
-
Horizon Technology Finance (AVTX) Q2 2024: Portfolio Yield Climbs to 15.9% as Pipeline Rebuilds
July 31, 2024
-
Horizon Technology Finance (AVTX) Q1 2024: Backlog Drops $50M as Origination Pace Stays Cautious
May 01, 2024
-
Horizon Technology Finance (AVTX) Q4 2023: Portfolio Yield Climbs to 16.8% as Venture Market Stays Stressed
February 28, 2024